Response by Wirtz et al to Letter Regarding Article, “Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries”
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
We greatly appreciate the positive comments regarding our article1 in the letter from Antignac et al. We agree that there is a dearth of published information about the quality of noncommunicable disease medicines including cardiovascular.
In 2011, contamination of a cardiovascular medicine in Lahore, Pakistan, caused nearly 200 deaths among up to 40 000 exposed patients.2,3 This major incident led to the establishment of the Judicial Inquiry Tribunal to determine the …